J&J Starts Trial on Bankruptcy Case Under Attack by Congress
- J&J strategy to end baby-powder lawsuits faces court test
- Company trying to use bankruptcy court to pay victim claims
This article is for subscribers only.
The controversial Johnson & Johnson bankruptcy strategy that’s drawn the ire of Congress faces a fresh trial this week, with the consumer products giant arguing that settling billions of dollars of talc liabilities in a single case is better for cancer victims than fighting thousands of individual claims.
J&J begins a week-long court hearing Monday to decide whether it wrongly manipulated the bankruptcy system by putting a unit into Chapter 11 solely to force a negotiated end to more than 38,000 lawsuits. The case has come under fire from advocates for people harmed by corporate malfeasance and in Congress, where legislation is being considered that would ban the company’s tactics.